Study to Evaluate the Relative Bioavailability of a New Formulation of NPT 2042 Soft-Gelatin Capsules Compared to the Original Formulation of NPT 2042

Clinical trial NCT07222878 · COMPLETED

Trial details

NCT number: NCT07222878
Sponsor: NeuroPro Therapeutics, Inc.
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Epilepsy Alzheimer Disease Epilepsy Intractable

Start date: 2025-09-29
Primary completion: 2025-11-04
Enrollment: 8

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.